Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Tebben

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Cardiovascular Pharmacology|June 27, 2003
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockersGary L Stump, Garry R Smith, Andrew J Tebben, et al.
Acta Crystallographica. Section D, Structural Biology|May 4, 2016
Crystal structures of apo and inhibitor-bound TGFβR2 kinase domain: insights into TGFβR isoform selectivityAndrew J Tebben, Maxim Ruzanov, Mian Gao, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2007
Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2)Percy H Carter, Gregory D Brown, Sarah R Friedrich, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2007
From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonistsDaniel S Gardner, Joseph B Santella, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2017
Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloadsAndrew F Donnell, Yong Zhang, Erik M Stang, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2)Michael G Yang, Zili Xiao, Qing Shi, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitorsMark E Fraley, William F Hoffman, Robert S Rubino, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2012
Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbonePercy H Carter, Gregory D Brown, Sarah R King, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2015
Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2)Qingjie Liu, Douglas G Batt, Jonathan S Lippy, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|June 27, 2003
In vivo canine cardiac electrophysiologic profile of 1,4-benzodiazepine IKs blockersGary L Stump, Garry R Smith, Andrew J Tebben, et al.
Acta Crystallographica. Section D, Structural Biology|May 4, 2016
Crystal structures of apo and inhibitor-bound TGFβR2 kinase domain: insights into TGFβR isoform selectivityAndrew J Tebben, Maxim Ruzanov, Mian Gao, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonistsRobert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2007
Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2)Percy H Carter, Gregory D Brown, Sarah R Friedrich, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2007
From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonistsDaniel S Gardner, Joseph B Santella, Andrew J Tebben, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2017
Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloadsAndrew F Donnell, Yong Zhang, Erik M Stang, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2012
Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2)Michael G Yang, Zili Xiao, Qing Shi, et al.
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitorsMark E Fraley, William F Hoffman, Robert S Rubino, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2012
Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbonePercy H Carter, Gregory D Brown, Sarah R King, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2015
Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2)Qingjie Liu, Douglas G Batt, Jonathan S Lippy, et al.
Pageof 5